| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $4.63M | $2.98M | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $212.98M | $205.45M | $204.79M | $116.54M | $84.47M |
| R&D | $160.64M | $155.29M | $147.91M | $86.72M | $70.55M |
| SG&A | $52.35M | $50.16M | $43.39M | $29.82M | $13.92M |
| Operating Income | -$208.35M | -$202.47M | -$204.79M | -$116.54M | -$84.47M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | -$279.00K | -$948.00K | -$486.00K |
| Net Income | -$201.14M | -$195.88M | -$198.13M | -$121.82M | -$165.37M |
| EPS (basic) | -1.3500 | -1.6500 | -2.1800 | -4.1900 | -14.1900 |
| EPS (diluted) | -1.3500 | -1.6500 | -2.1800 | -4.1900 | -14.1900 |
| Shares (diluted) | $148.76M | $118.60M | $90.97M | $33.89M | $12.97M |